Quest Diagnostics
817 hedge funds and large institutions have $14.8B invested in Quest Diagnostics in 2021 Q1 according to their latest regulatory filings, with 94 funds opening new positions, 282 increasing their positions, 290 reducing their positions, and 81 closing their positions.
16% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 81
14% more call options, than puts
Call options by funds: $60.7M | Put options by funds: $53.4M
5% more capital invested
Capital invested by funds: $14B → $14.8B (+$759M)
1% more funds holding
Funds holding: 811 → 817 (+6)
0.12% more ownership
Funds ownership: 86.69% → 86.81% (+0.12%)
3% less repeat investments, than reductions
Existing positions increased: 282 | Existing positions reduced: 290
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$164M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$77.5M |
| 3 |
Two Sigma Investments
New York
|
+$50.6M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$50.5M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$50.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$181M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$94.4M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$64.5M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$62.3M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$51.9M |
DGX Hedge Fund Activity: Q1 2021 in Review
817 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2021, worth a combined $14.8B — up 5.4% from $14B a quarter earlier.
Buyers outnumbered sellers: 94 funds opened new DGX positions and 81 closed out — a net gain of 13 holders — while 282 added to existing stakes and 290 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $164M. The largest seller was JP Morgan Chase, cutting an estimated $181M.
- 817 institutional investors held Quest Diagnostics (DGX) as of Q1 2021, up from 811 in Q4 2020.
- Funds reported $14.8B of Quest Diagnostics stock for Q1 2021, up 5.4% quarter-over-quarter.
- 94 funds opened new Quest Diagnostics positions in Q1 2021 and 81 closed out, a net change of +13 holders.
- The largest Quest Diagnostics buyer in Q1 2021 was First Trust Advisors, an estimated $164M added.
- The largest Quest Diagnostics seller in Q1 2021 was JP Morgan Chase, an estimated $181M sold.
Based on aggregated 13F filings for Q1 2021.